Clinical value of serum interleukin-18 in patients with prostate cancer

Chinese-German Journal of Clinical Oncology

Volumn 6, Issue 6, 2007, Pages 574-578

  Nong, Shaojun ^a   Wen, Duangai ^a   Fan, Caibin ^a   Ouyang, Jun ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Interleukin 18 (IL 18); Prostate cancer

Indexed keywords

EID: 37549071783     PISSN: 16101979     EISSN: 16139089     Source Type: Journal    
DOI: 10.1007/s10330-007-0134-0     Document Type: Article

References (25)

1. Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol, 2003, 73: 213-224.
2. Sugawara S, Uehara A, Nochi T, et al. Neutrophil proteinase 3-mediated induction of bioactivel IL-18 secretion by human oral epithelial cells. J Immunol, 2001, 167: 6568-6575.
3. Fukuhara H, Ino Y, Kuroda T, et al. Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system. Cancer Res, 2005, 65: 10663-10668.
4. Cao DY, Yang JY, Dou KF, et al. Alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4-and CD8-mediated T-cell response from hepatocellular carcinoma patients in vitro. Hum Immunol, 2007, 68: 334-341.
5. Gunel N, Cokun U, Sancak B, et al. Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients. Cancer, 2002, 95: 663-667.
6. Fang P, Hwa V, Ronsenfeld RG. Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway. Exp Cell Res, 2006, 312: 1229-1239.
7. Shou J, Soriano R, Hayward SW, et al. Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression. Proc Natl Acad Sci USA, 2002, 99: 2830-2835.
8. Lebel-Binay S, Thiounn N, De Pinieux G, et al. IL-18 is produced by prostate cancer cells and secreted in response to interferons. Int J Cancer, 2003, 106: 827-835.
9. Lorey SL, Huang YC, Sharma V. Constitutive expression of interleukin-18 and interleukin-18 receptor mRNA in tumour derived human B-cell lines. Clin Exp Immunol, 2004, 136: 456-462.
10. Martone T, Bellone G, Pagano M, et al. Constitutive expression of interleukin-18 in head and neck squamous carcinoma cells. Head Neck, 2004, 26: 494-503.
11. Wang ZY, Gaggero A, Rubartelli A, et al. Expression of interleukin-18 in human ovarian carcinoma and normal ovarian epithelium: Evidence for defective processing in tumor cells. Int J Cancer, 2002, 98: 873-878.
12. Kawabata T, Ichikura T, Majima T, et al. Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma. Cancer, 2001, 92: 2050-2055.
13. Tsuboi K, Miyazaki T, Nakajima M, et al. Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma. Cancer Lett, 2004, 205: 207-214.
14. Gunel N, Coskun U, Sancak B, et al. Prognostic value of serum IL-18 and nitric oxide activity in breast cancer patients at operable stage. Am J Clin Oncol, 2003, 26: 416-421.
15. Chernavsky AC, Paladino N, Rubio AE, et al. Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children. Hum Immunol, 2004, 65: 683-691.
16. Ueda H, Kashiwamura S, Sekiyama A, et al. Production of IL-13 in spleen cells by IL-18 and IL-12 through generation of NK-like cells. Cytokine, 2006, 33: 179-187.
17. Liu Q, Liu Z, Whitmire J, et al. IL-18 stimulates IL-13-mediated IFN-gamma-sensitive host resistance in vivo. Eur J Immunol, 2006, 36: 1187-1198.
18. Chia CS, Ban K, Ithnin H, et al. Expression of interleukin-18, interferon-gamma and interleukin-10 in hepatocellular carcinoma. Immunol Lett, 2002, 84: 163-172.
19. Herling M, Rassidakis GZ, Medeiros LJ, et al. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: Associations with presenting features, serum interleukin 10 levels, and clinical outcome. Clin Cancer Res, 2003, 9: 2114-2120.
20. De Vita F, Orditura M, Galizia G, et al. Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients. Chest, 2000, 117: 365-373.
21. Galizia G, Orditura M, Romano C, et al. Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin Immunol, 2002, 102: 169-178.
22. Cornish J, Gillespie MT, Callon KE, et al. Interleukin-18 is a novel mitogen of osteogenic and chondrogenic cells. Endocrinology, 2003, 144: 1194-1201.
23. Iwasaki T, Yamashita K, Tsujimura T, et al. Interleukin-18 inhibits osteolytic bone metastasis by human lung cancer cells possibly through suppression of osteoclastic bone-resorption in nude mice. J Immunother, 2002, 25Suppl 1: S52-S60.
24. Wallner L, Dai J, Escara-Wilke J, et al. Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice. Cancer Res, 2006, 66: 3087-3095.
25. Mendoza L, Carrascal T, De Luca M, et al. Hydrogen peroxide mediates vascular cell adhesion molecule-1 expression from interleukin-18-activated hepatic sinusoidal endothelium: Implications for circulating cancer cell arrest in the murine liver. Hepatology, 2001, 34: 298-310.